Morrison & Foerster LLP
Anti-CD33 antibodies and methods of use thereof
The present disclosure is generally directed to compositions that include antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and have improved and/or enhanced functional characteristics, and use of such compositions in preventing, reducing risk, or treating an individual in need thereof.
ALECTOR LLC
A C C C C C C A C C C
A61K C07K C07K C07K C07K C07K C07K A61K C07K C07K C07K
additional inventional additional additional inventional additional additional additional additional additional additional
Arnon Patricia Helen Robert Seung-Joo Nels P.
Rosenthal Culp Lam Pejchal Lee Nielson